Definitive healthcare corp. reports inducement grants under nasdaq listing rule 5635(c)(4)

Framingham, mass., june 25, 2024 (globe newswire) -- definitive healthcare (nasdaq: dh), an industry leader in healthcare commercial intelligence, today announced that definitive healthcare's board of directors (the “board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“psus”) and 1,170,047 time-based restricted stock units (“rsus”) to kevin coop, definitive healthcare's new chief executive officer and member of the board, effective june 24, 2024. the awards were granted as an inducement material to mr. coop's commencement of employment with definitive healthcare in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking